BIIB position history
The shares of Biogen (BIIB) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 170,859 shares, $48M, 0.24% of portfolio
- 2021 Q4: 147,709 shares, $35M, 0.19% of portfolio, Reduce −13.5%
- 2022 Q1: 197,799 shares, $42M, 0.22% of portfolio, Add +33.9%
- 2022 Q2: 278,499 shares, $57M, 0.35% of portfolio, Add +40.8%
- 2022 Q3: 305,499 shares, $82M, 0.48% of portfolio, Add +9.7%
- 2022 Q4: 592,699 shares, $164M, 1.1% of portfolio, Add +94.0%
- 2023 Q1: 619,798 shares, $172M, 0.98% of portfolio, Add +4.6%
- 2023 Q2: 604,098 shares, $172M, 0.96% of portfolio, Reduce −2.5%
- 2023 Q3: not held, Exit
- 2023 Q4: not held
- 2024 Q1: not held
- 2024 Q2: not held
- 2024 Q3: not held
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: not held
- 2026 Q1: not held
- 2026 Q2: 71,000 shares, $15M, 0.07% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|